Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients

Clinical Cancer Research

Volumn 9, Issue 7, 2003, Pages 2545-2550

  Gao, Chun Ling ^a   Rawal, Sudhir K ^a   Sun, Leon ^a   Ali, Amina ^a   Connelly, Roger R ^a   Bañez, Lionel L ^a   Sesterhenn, Isabell A ^b   McLeod, David G ^c   Moul, Judd W ^c   Srivastava, Shiv ^a,b  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; BLOOD ANALYSIS; CANCER DIAGNOSIS; CANCER SCREENING; CANCER SURGERY; CELL ISOLATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; HYPOTHESIS; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; EPITHELIAL CELLS; HUMANS; MAGNETICS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA;

EID: 12444265691     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Sidransky, D. Emerging molecular markers of cancer. Nat. Rev. Cancer, 2: 210-219, 2002.
2. Jen, J., Wu, L., and Sidransky, D. An overview on the isolation and analysis of circulating tumor DNA in plasma and serum. Ann. N. Y. Acad. Sci., 906: 8-12, 2000.
3. Moul, J. W., Kane, C. J., and Malkowicz, S. B. The role of imaging studies and molecular markers for selecting candidates for radical prostatectomy. Urol. Clin. N. Am., 28: 459-472, 2001.
4. Barry, M. J. Prostate-specific antigen testing for early diagnosis of prostate cancer. N. Engl. J. Med., 344: 1373-1377, 2001.
5. Carroll, P., Coley, C., McLeod, D., Schellhammer, P., Sweat, G., Wasson, J., Zietman, A., and Thompson, I. Prostate-specific antigen best practice policy - part II: prostate cancer staging and post-treatment follow-up. Urology, 57: 225-229, 2001.
6. Augustus, M., Moul, J. W., and Srivastava, S. The molecular phenotype of the malignant prostate. In: S. Srivastava, D. E. Henson, and A. Gazden (eds.), Molecular Pathology of Early Cancer, pp. 321-340. Amsterdam: IOS Press, 1999.
7. Moreno, J. G., Croce, C. M., Fischer, R., Monne, M., Vihko, P., Mulholland, S. G., and Gomella, L. G. Detection of hematogenous micrometastasis in patients with prostate cancer. Cancer Res., 52: 6110-6112, 1992.
8. Vessella, R. L., Blouke, K. A., and Stray, J. E. The use of the polymerase chain reaction to detect metastatic prostate cancer cells in lymph nodes and bone marrow. Proc. Am. Assoc. Cancer Res., 33: 396, 1992.
9. Katz, A. E., Olsson, C. A., Raffo, A. J., Cama, C., Perlman, H., Seaman, E., O'Toole, K. M., McMahon, D., Benson, M. C., and Buttyan, R. Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay. Urology, 43: 765-775, 1994.
10. Katz, A. E., De Vries, G. M., Olsson, C. A., Benson, M. C., Swanton, P., Ikeguchi, E. F., and Buttyan, R. Molecular staging of genitourinary malignancies. Urology, 47: 948-958, 1996.
11. de la, Taille, A., Olsson, C. A., Buttyan, R., Benson, M. C., Bagiella, E., Cao, Y., Burchardt, M., Chopin, D. K., and Katz, A. E. Blood-based reverse transcriptase polymerase chain reaction assays for prostatic specific antigen: long term follow-up confirms the potential utility of this assay in identifying patients more likely to have biochemical recurrence (rising PSA) following radical prostatectomy. Int. J. Cancer, 84: 360-364, 1999.
12. Sokoloff, M. H., Tso, C. L., Kaboo, R., Nelson, S., Ko, J., Dorey, F., Figlin, R. A., Pang, S., deKernion, J., and Belldegrun, A. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J. Urol., 156: 1560-1566, 1996.
13. Melchior, S. W., Corey, E., Ellis, W. J., Ross, A. A., Layton, T. J., Oswin, M. M., Lange, P. H., and Vessella, R. L. Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate. Clin. Cancer Res., 3: 249-256, 1997.
14. Ignatoff, J. M., Oefelein, M. G., Watkin, W., Chmiel, J. S., and Kaul, K. L. Prostate specific antigen reverse transcriptase-polymerase chain reaction assay in preoperative staging of prostate cancer. J. Urol., 158: 1870-1874, 1997.
15. Henke, W., Jung, M., Jung, K., Lein, M., Schlechte, H., Berndt, C., Rudolph, B., Schnorr, D., and Loening, S. A. Increased analytical sensitivity of RT-PCR of PSA mRNA decreases diagnostic specificity of detection of prostatic cells in blood. Int. J. Cancer, 70: 52-56, 1997.
16. Sardi, I., Piazzini, M., Ponchietti, R., Fatini, C., Di Loro, F., and Guazzelli, R. The use of RT-"nested." PCR of prostate specific antigen to detect hematogenous neoplastic cells in patients with prostate adenocarcinoma. J. Mol. Med., 75: 751-757, 1997.
17. de Cremoux, P., Ravery, V., Podgorniak, M. P., Chevillard, S., Toublanc, M., Thiounn, N., Tatoud, R., Delmas, V., Calvo, T., and Boccon-Gibod, L. Value of the preoperative detection of prostate-specific antigen-positive circulating cells by nested RT-PCR in patients submitted to radical prostatectomy. Eur. Urol., 32: 69-74, 1997.
18. Thiounn, N., Saporta, F., Flam, T. A., Pages, F., Zerbib, M., Vieillefond, A., Martin, E., Debre, B., and Chevillard, S. Positive prostate specific antigen circulating cells detected by reverse transcriptase polymerase chain reaction does not imply the presence of prostatic micrometastases. Urology, 50: 245-250, 1997.
19. Gao, C. L., Maheshwari, S., Dean, R. C., Tatum, L., Mooneyhan, R., Connelly, R. R., McLeod, D. G., Srivastava, S., and Moul, J. W. Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer. Urology, 53: 714-721, 1999.
20. Wood, D. P., Jr., and Banerjee, M. Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease free survival. J. Clin. Oncol., 15: 3451-3457, 1997.
21. Gao, C. L., Dean, R. C., Pinto, A., Mooneyhan, R., Connelly, R. R., McLeod, D. G., Srivastava, S., and Moul, J. W. Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction. J. Urol., 161: 1070-1076, 1999.
22. Bianco, F. J., Jr., Wood, D. P., Jr., Gomes de Oliveira, J., Nemeth, J. A., Beaman, A. A., and Cher, M. L. Proliferation of prostate cancer cells in the bone marrow predicts recurrence in patients with localized prostate cancer. Prostate, 49: 235-242, 2001.
23. Ferrari, A. C., Stone, N. N., Eyler, J. N., Gao, M., Mandeli, J., Unger, P., Gallagher, R. E., and Stock, R. Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer. J. Natl. Cancer Inst. (Bethesda), 89: 1498-1504, 1997.
24. Edelstein, R. A., Zietman, A. L., de las Morenas, A., Krane, R. J., Babayan, R. K., Dallow, K. C., Traish, A., and Moreland, R. B. Implications of prostate micrometastases in pelvic lymph nodes: an archival tissue study. Urology, 47: 370-375, 1996.
25. Deguchi, T., Doi, T., Ehara, H., Ito, S., Takahashi, Y., Nishino, Y., Fujihiro, S., Kawamura, T., Komeda, H., and Horie, M. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res., 53: 5350-5354, 1993.
26. Moreno, J. G., and Gomella, L. G. Circulating prostate cancer cells detected by reverse transcription-polymerase chain reaction (RT-PCR): what do they mean? Cancer Control, 5: 507-512, 1998.
27. Su, S. L., Boynton, A. L., Holmes, E. H., Elgamal, A. A., and Murphy, G. P. Detection of extraprostatic prostate cells utilizing reverse transcription-polymerase chain reaction. Semin. Surg. Oncol., 18: 17-28, 2000.
28. Bauer, J. J., Zeng, J., Weir, J., Zhang, W., Sesterhenn, I. A., Connelly, R. R., Mun, S. K., and Moul, J. W. Three-dimensional computer-simulated prostate models: lateral prostate biopsies increase the detection rate of prostate cancer. Urology, 53: 961-967, 1999.
29. Sun, L., Gancarczyk, K., and Paquette, E. L. Introduction to Department of Defense Center for Prostate Disease Research Multicenter National Prostate Cancer Database and analysis of changes in the PSA era. Urol. Oncol., 6: 203-209, 2001.
30. Jani, A. B., Vaida, F., Hanks, G., Asbell, S., Sartor, O., Moul, J. W., Roach, M., III, Brachman, D., Kalokhe, U., Muller-Runkel, R., Ray, P., Ignacio, L., Awan, A., Weichselbaum, R. R., and Vijayakumar, S. Changing face and different countenances of prostate cancer: racial and geographic differences in prostate-specific antigen (PSA), stage, and grade trends in the PSA era. Int. J. Cancer, 96: 363-371, 2001.
31. Garnick, M. B., and Fair, W. R. Combating prostate cancer. Sci. Am., 279: 74-83, 1998.
32. Moul, J. W. Prostate specific antigen only progression of prostate cancer. J. Urol., 163: 1632-1642, 2000.
33. Brandt, B., Junker, R., Griwatz, C., Heidl, S., Brinkmann, O., Semjonow, A., Assmann, G., and Zanker, K. S. Isolation of prostate-derived single cells and cell clusters from human peripheral blood. Cancer Res., 56: 4556-4561, 1996.
34. Wang, Z. P., Eisenberger, M. A., Carducci, M. A., Partin, A. W., Scher, H. I., and Tso, P. O. Identification and characterization of circulating prostate carcinoma cells. Cancer (Phila.), 88: 2787-2795, 2000.
35. Moreno, J. G., O'Hara, S., Gross, S., Doyle, G., Fritsche, H., Gomella, L. G., and Terstappen, L. W. M. M. Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease status. Urology, 58: 386-392, 2001.
36. Racila, E., Euhus, D., Weiss, A. J., Rao, C., McConnell, J., Terstappen, L. W., and Uhr, J. W. Detection and characterization of carcinoma cells in the blood. Proc. Natl. Acad. Sci. USA, 95: 4589-4594, 1998.
37. Sabile, A., Louha, M., Bonte, E., Poussin, K., Vona, G., Mejean, A., Chretien, Y., Bougas, L., Lacour, B., Capron, F., Roseto, A., Brechot, C., and Paterlini-Brechot, P. Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection. Am. J. Clin. Pathol, 112: 171-178, 1999.
38. de la Taille, A., Muscatelli, B., Colombel, M., Jouault, H., Amsellem, S., Mazeman, E., Abbou, C. C., and Chopin, D. In vitro detection of prostate cancer circulating cells by immunocytochemistry, flow cytometry and RT-PCR PSA. Prog. Urol., 8: 1058-1064, 1998.
39. Goessl, C., Muller, M., Heicappell, R., Krause, H., and Miller, K. DNA-based detection of prostate cancer in blood, urine, and ejaculates. Ann. N. Y. Acad. Sci., 945: 51-58, 2001.
40. Israeli, R. S., Miller, W. H., Jr., Su, S. L., Powell, C. T., Fair, W. R., Samadi, D. S., Huryk, R. F., DeBlasio, A., Edwards, E. T., and Wise, G. J. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res., 54: 6306-6310, 1994.
41. Bussemakers, M. J., van Bokhoven, A., Verhaegh, G. W., Smit, F. P., Karthaus, H. F., Schalken, J. A., Debruyne, F. M., Ru, N., and Isaacs, W. B. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res., 59: 5975-5979, 1999.
42. Srikantan, V., Zou, Z., Petrovics, G., Xu, L., Augustus, M., Davis, L., Livezey, J. R., Connell, T., Sesterhenn, I. A., Yoshino, K., Buzard, G. S., Mostofi, F. K., McLeod, D. G., Moul, J. W., and Srivastava, S. PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer. Proc. Natl. Acad. Sci. USA, 97: 12216-12221, 2000.
43. Xu, L. L., Stackhouse, B. G., Florence, K., Zhang, W., Shanmugam, N., Sesterhenn, I. A., Zou, Z., Srikantan, V., Augustus, M., Roschke, V., Carter, K., McLeod, D. G., Moul, J. W., Soppett, D., and Srivastava, S. PSGR, a novel prostate-specific gene with homology to a G protein-coupled receptor, is overexpressed in prostate cancer. Cancer Res., 60: 6568-6572, 2000.